How to Create a Clinical Evaluation Plan (CEP) under EU MDR

by | Apr 22, 2024 | Clinical Trials, Compliance, EU, EU MDR, FDA, Global Leader, GMP, Medicine, MedTech, Regulatory

In the ever-evolving landscape of medical device regulation, the Clinical Evaluation Plan (CEP) stands as a cornerstone for ensuring the safety, performance, and effectiveness of medical devices under the European Union Medical Device Regulation (EU MDR). Crafting a robust CEP not only demonstrates conformity with regulatory requirements but also underscores a manufacturer’s commitment to patient safety and product quality. In this blog, we’ll explore the essentials of writing a comprehensive Clinical Evaluation Plan under EU MDR, offering insights and best practices to navigate this critical aspect of regulatory compliance.

The Clinical Evaluation Plan serves as a roadmap for assessing and documenting the clinical evidence supporting the safety and performance of a medical device. It outlines the methodology, objectives, and criteria for conducting clinical evaluations and provides a structured approach to gathering, analyzing, and interpreting clinical data.

Key elements of the CEP include:

  • Scope and Objectives: Clearly define the scope and objectives of the clinical evaluation, including the intended use of the device, target patient population, and clinical endpoints to be evaluated.
  • Methodology and Study Design: Describe the methodology and study design proposed for the clinical evaluation, including the type of clinical data to be collected, study endpoints, sample size calculation, and statistical analysis plan.
  • Risk Assessment: Conduct a thorough risk assessment to identify and mitigate potential risks associated with the device’s clinical use. This includes assessing known and foreseeable risks, as well as any new or emerging risks.
  • Literature Review: Conduct a comprehensive review of existing clinical literature and post-market surveillance data relevant to the device, including peer-reviewed studies, clinical investigations, and adverse event reports.
  • Clinical Data Collection and Analysis: Outline the procedures for collecting, analyzing, and interpreting clinical data, including data sources, data management processes, and statistical methods.
  • Post-Market Surveillance and Follow-Up: Describe the plans for post-market surveillance and ongoing monitoring of the device’s safety and performance once it is placed on the market.

A CEP should be an extremely detailed and involved document within your technical file. It will undergo a thorough assessment by your notified body to ensure that it meets all regulations and requirements. This assessment involves a comprehensive review of the clinical evidence and methodology outlined in the CEP to determine whether it meets regulatory requirements and provides sufficient data to support the device’s conformity with EU MDR standards.

The technical assessment begins with a thorough review of the CEP to ensure compliance with the requirements set forth in EU MDR. This includes verifying that the CEP addresses all relevant sections and annexes of the regulation, such as:

  • Annex XIV for the requirements concerning clinical evaluation and post-market clinical follow-up.
  • Annex XV for the requirements regarding clinical evidence for Class III and implantable devices (if applicable).
  • Annex XVI for the requirements concerning clinical evidence for devices without a medical purpose (if applicable).

The technical assessment scrutinizes the clinical evidence presented in the CEP, evaluating the quality, relevance, and sufficiency of the data collected. This involves reviewing the methodology for data collection, including study design, patient population, endpoints, and statistical analysis plan. Additionally, reviewers will assess the strength of the clinical evidence, considering factors such as sample size, study duration, patient demographics, and follow-up procedures.

Crafting a robust Clinical Evaluation Plan is essential for demonstrating the safety, performance, and effectiveness of medical devices under EU MDR. By following a structured approach and adhering to best practices, manufacturers can develop CEPs that meet regulatory requirements, mitigate risks, and provide robust clinical evidence to support market access and patient safety. Let the EU MDR experts at EMMA International help develop your CEP! Call us at 248-987-4497 or email to get in touch with our team of experts today.

MDCG (March 2020) The Clinical Evaluation Process retrieved from:

EMMA International

EMMA International

EMMA International Consulting Group, Inc. is a global leader in FDA compliance consulting. We focus on quality, regulatory, and compliance services for the Medical Device, Combination Products, and Diagnostics industries.

More Resources

Ready to learn more about working with us?

Pin It on Pinterest

Share This